PKC-θ is a drug target for prevention of T cell-mediated autoimmunity and allograft rejection.
Kwon
Myung-Ja
MJ
Beckman Research Institute of the City of Hope, Duarte, CA 91010, Los Angeles, USA.
Wang
Ruiqing
R
Ma
Jian
J
Sun
Zuoming
Z